Feasibility of a Mobile Health Application To Monitor Recovery and Patient-reported Outcomes after Robot-assisted Radical Prostatectomy

Belarmino, Andre; Walsh, Ryan; Alshak, Mark N.; Patel, Neal; Wü, Ray; Hu, Jim C.

doi:10.1016/j.euo.2018.08.016

Cited by 41 publications

(43 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most of the patients (85%) complied with ambulation, hydration and Kegel's exercising app notification. Patients found this mobile app comprehensible and easy to use, which gives an opportunity for improving compliance in perioperative instructions [38]. On the contrary, Lange and colleagues draw attention that guided online peer chat was not an effective support tool and demonstrated poorer psychological outcomes in patients using this app compared to control group [39].…”

Section: Belarmino Et Al Had Recently Demonstrated a Mobile Applicatmentioning

confidence: 99%

Changes in management of patients with cancer during COVID-19 pandemic

Kosz

Zarankiewicz

Zielińska

et al. 2020

J Educ Health Sport

View full text Add to dashboard Cite

Introduction: As of March 11, 2020, COVID-19 has been declared as a global pandemic. It has spread rapidly and profoundly impact the function of health care system all around the world. As a result, management and organisation of oncology units had to be altered in order to provide security measures and safe care for patients. Purpose: The aim of this paper is to review current knowledge involving management of patients with malignancies during COVID-19 pandemic. Particular attention has been paid to changes in diagnosis, treatment and follow-up of patients with cancer. Material and methods: The review includes publications released in 2019 and 2020. The data has been collected by the use of PubMed, WHO website and other online published guidance. Results: As a lot of clinical trials has been suspended, current therapy options for patients with cancer has been also limited. Moreover, patients became fearful of becoming infected by SARS-CoV-2 and accordingly they were less likely to attend screening programmes. Additionally, as the amount of surgeries has been reduced, the need for radiotherapy service has increased. Chemotherapy has been found to be risky for patients with cancer as it may favour them to SARS-CoV-2 infection. Conclusions: Appropriate security measures need to be implemented in order to protect against SARS-CoV-2 infection but optimal health care access should be provided as well. There is a high necessity to share knowledge and experience on the impact of pandemic on patients with malignancies. However, a lot of patients are fearful of COVID-19, adverse effects of delayed diagnosis, treatment and follow-up should not be diminished.

show abstract

Section: Belarmino Et Al Had Recently Demonstrated a Mobile Applicatmentioning

confidence: 99%

Changes in management of patients with cancer during COVID-19 pandemic

Kosz

Zarankiewicz

Zielińska

et al. 2020

J Educ Health Sport

View full text Add to dashboard Cite

show abstract

“…In total, 17 web-based e-SRS were reported in 22 studies (22/33, 66%) [27][28][29][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49], including 2 studies that integrated web-based platforms with patient portals and electronic health records (EHRs) [41,47]. A total of 9 studies presented 7 mobile app-based e-SRS (9/33, 27%) [30,[50][51][52][53][54][55][56][57], 1 study reported an interactive voice response system [58], and 1 study used only text messaging for symptom reporting [59]. The most commonly adopted symptom reporting instruments or questionnaires in home-based e-SRS were the National Cancer Institute-Common Terminology Criteria for Adverse Events or patient-reported outcome version of Common Terminology Criteria for Adverse Events (6/33, 19%) [27,28,30,38,46,48] [28,31,45,…”

Section: Summary Of Study Characteristicsmentioning

confidence: 99%

“…Mobile app-based systems showed lower enrollment rates than that of web-based systems (median 57% vs 71%). Among the 7 out of 23 studies that used mobile app-based systems [30,[50][51][52][53]55,56], 4 studies (enrollment rates=40%-57%, 22/25-38/67) [50,51,53,56] showed that the most common reason for rejection was that patients did not have devices (eg, smartphones) or their devices were not compatible with the e-SRS platform (eg, iPhone or Android phone mismatched). A total of 2 studies using mobile app-based systems had relatively high enrollment rates (64/75, 85% and 66/107, 61.7%) because both studies provided mobile devices for participation [52,55].…”

Section: E-srs Acceptancementioning

confidence: 99%

See 1 more Smart Citation

Acceptance and Use of Home-Based Electronic Symptom Self-Reporting Systems in Patients With Cancer: Systematic Review

Cho¹,

Zhang²,

Harris³

et al. 2021

J Med Internet Res

View full text Add to dashboard Cite

Background Electronic symptom self-reporting systems (e-SRS) have been shown to improve symptoms and survival in patients with cancer. However, patient engagement in using e-SRS for voluntary symptom self-reporting is less optimal. Multiple factors can potentially affect patients’ acceptance and engagement in using home-based e-SRS. However, such factors have not been fully explored in cancer populations. Objective The aim of this study is to understand the acceptance and use of home-based e-SRS by patients with cancer and identify associated facilitators and barriers. Methods PubMed, CINAHL, Scopus, and PsycINFO (January 2010 to March 2020) were searched using a combination of Medical Subject Headings (MeSH) terms and keywords such as symptom self-reporting, electronic/technology, cancer, and their synonyms. Included studies focused on the use of home-based e-SRS by patients with cancer and their families. Studies on patients’ use of e-SRS in clinical settings only were excluded. Of the 3740 papers retrieved, 33 were included in the final review. Factors associated with patient acceptance and use of e-SRS were extracted and synthesized. Results Most e-SRS were web based (22/33, 66%) or mobile app based (9/33, 27%). The e-SRS initial acceptance, represented by patient enrollment rates, ranged from 40% (22/55) to 100% (100/100). High e-SRS acceptance was rated by 69% (59/85) to 77.6% (337/434) of the patients after they used the system. The e-SRS use, measured by patients’ response rates to questionnaires (ranging from 1596/3521, 45.33% to 92%) or system log-on rates (ranging from 4/12, 33% to 99/100, 99%), declined over time in general patterns. Few studies (n=7) reported e-SRS use beyond 6 months, with the response rates ranging from 62% (40/64) to 85.1% (541/636) and the log-on rates ranging from 63.6% (103/162) to 77% (49/64). The availability of compatible devices and technical support, interactive system features, information accessibility, privacy, questionnaire quality, patient physical/psychosocial status, and age were associated with patient acceptance and use of home-based e-SRS. Conclusions Acceptance and use of home-based e-SRS by patients with cancer varied significantly across studies, as assessed by a variety of approaches. The lack of access to technology has remained a barrier to e-SRS adoption. Interactive system features and personalized questionnaires may increase patient engagement. More studies are needed to further understand patients’ long-term use of home-based e-SRS behavior patterns to develop personalized interventions to support symptom self-management and self-reporting of patients with cancer for optimal health outcomes.

show abstract

“…Leahy et al [21] showed similar satisfaction after radiotherapy for nurse-led telephone consultations to standard office visits. Recently, Belarmino and colleagues [22] demonstrated a smartphone app for monitoring of postoperative recovery and Kegel teaching following prostatectomy. Lange et al [23] offered some cautionary data demonstrating poorer psychological outcomes for patients utilising an online peer chat group compared with usual care.…”

Section: Evidence Synthesismentioning

confidence: 99%

The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the Future

et al. 2020

View full text Add to dashboard Cite

Context The coronavirus disease 2019 (COVID-19) pandemic necessitated rapid changes in medical practice. Many of these changes may add value to care, creating opportunities going forward. Objective To provide an evidence-informed, expert-derived review of genitourinary cancer care moving forward following the initial COVID-19 pandemic. Evidence acquisition A collaborative narrative review was conducted using literature published through May 2020 (PubMed), which comprised three main topics: reduced in-person interactions arguing for increasing virtual and image-based care, optimisation of the delivery of care, and the effect of COVID-19 in health care facilities on decision-making by patients and their families. Evidence synthesis Patterns of care will evolve following the COVID-19 pandemic. Telemedicine, virtual care, and telemonitoring will increase and could offer broader access to multidisciplinary expertise without increasing costs. Comprehensive and integrative telehealth solutions will be necessary, and should consider patients’ mental health and access differences due to socioeconomic status. Investigations and treatments will need to maximise efficiency and minimise health care interactions. Solutions such as one stop clinics, day case surgery, hypofractionated radiotherapy, and oral or less frequent drug dosing will be preferred. The pandemic necessitated a triage of those patients whose treatment should be expedited, delayed, or avoided, and may persist with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in circulation. Patients whose demographic characteristics are at the highest risk of complications from COVID-19 may re-evaluate the benefit of intervention for less aggressive cancers. Clinical research will need to accommodate virtual care and trial participation. Research dissemination and medical education will increasingly utilise virtual platforms, limiting in-person professional engagement; ensure data dissemination; and aim to enhance patient engagement. Conclusions The COVID-19 pandemic will have lasting effects on the delivery of health care. These changes offer opportunities to improve access, delivery, and the value of care for patients with genitourinary cancers but raise concerns that physicians and health administrators must consider in order to ensure equitable access to care. Patient summary The coronavirus disease 2019 (COVID-19) pandemic has dramatically changed the care provided to many patients with genitourinary cancers. This has necessitated a transition to telemedicine, changes in threshold or delays in many treatments, and an opportunity to reimagine patient care to maintain safety and improve value moving forward.

show abstract

Feasibility of a Mobile Health Application To Monitor Recovery and Patient-reported Outcomes after Robot-assisted Radical Prostatectomy

Cited by 41 publications

References 11 publications

Changes in management of patients with cancer during COVID-19 pandemic

Changes in management of patients with cancer during COVID-19 pandemic

Acceptance and Use of Home-Based Electronic Symptom Self-Reporting Systems in Patients With Cancer: Systematic Review

The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the Future

Contact Info

Product

Resources

About